E Fund Management Co., Ltd.

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1842296 GUANGZHOU, F4

Position in KYMR

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$2,184,779

+$217,889 QoQ

Shares Held

26,231

-63.5% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

E Fund Management Co., Ltd. holds $77,672,385 across 116 Biotechnology names. KYMR ranks #7 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SMMT	Summit Therapeutics Inc.	311,825	$5,912,202
2	EVMN	Evommune, Inc.	243,700	$5,602,663
3	CELC	Celcuity Inc.	46,337	$5,288,905
4	VRTX	Vertex Pharmaceuticals Inc / Ma	10,816	$4,829,776
5	REGN	Regeneron Pharmaceuticals, Inc.	4,825	$3,727,988
6	IONS	Ionis Pharmaceuticals Inc	46,688	$3,505,801
7	KYMR	Kymera Therapeutics, Inc. This page	26,231	$2,184,779
8	AVBP	ArriVent BioPharma, Inc.	93,953	$2,167,495

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,184,779	26,231	-63.5%	Shares	Defined	2026-04-13
2025-03-31	$1,966,890	71,863	+7.1%	Shares	Sole	2025-05-13
2024-12-31	$2,698,145	67,068	+23.5%	Shares	Sole	2025-02-07
2024-09-30	$2,569,640	54,292	+10.9%	Shares	Sole	2024-11-13
2024-06-30	$1,461,038	48,946	+391.2%	Shares	Sole	2024-08-12
2024-03-31	$400,593	9,965	-13.6%	Shares	Sole	2024-05-13
2023-06-30	$265,074	11,530	-2.9%	Shares	Sole	2023-08-11
2023-03-31	$351,708	11,870	+5.1%	Shares	Sole	2023-05-11
2022-12-31	$281,848	11,292	-8.5%	Shares	Sole	2023-02-14
2022-09-30	$268,685	12,342	-28.4%	Shares	Sole	2022-11-14
2022-06-30	$339,514	17,243	+176.9%	Shares	Sole	2022-08-15
2022-03-31	$263,568	6,228	+97.7%	Shares	Sole	2022-05-12
2021-12-31	$199,993	3,150	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.